Clinical trial
Prostvac in Patients With Biochemically Recurrent Prostate Cancer
NCT02649439 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostvac in Patients With Biochemically Recurrent Prostate Cancer
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 22, 2015
- Completion date
- October 1, 2022
- Enrollment
- 97 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer